Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Clinical Immunology
Published in: Journal of Clinical Immunology 2/2014

01-02-2014 | Astute Clinician Report

X-Linked agammaglobulinemia in a child with Klinefelter’s syndrome

Authors: Alexis-Virgil Cochino, Ales Janda, Barbora Ravcukova, Vasilica Plaiasu, Diana Ochiana, Ioan Gherghina, Tomas Freiberger

Published in: Journal of Clinical Immunology | Issue 2/2014

Login to get access

Abstract

Bruton’s agammaglobulinemia is a rare X-linked humoral immunodeficiency manifesting with recurrent bacterial infections early in life. Klinefelter’s syndrome caused by an additional X chromosome is the most common sex chromosome disorder. A previously unreported association of these two conditions is described here.
Literature
1.
Winkelstein JA et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore). 2006;85(4):193–202.CrossRef
2.
Ochs HD, Smith CI. X-linked agammaglobulinemia. A clinical and molecular analysis. Medicine (Baltimore). 1996;75(6):287–99.CrossRef
3.
Nielsen J, Wohlert M. Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Birth Defects Orig Artic Ser. 1990;26(4):209–23.PubMed
4.
Tuttelmann F, Gromoll J. Novel genetic aspects of Klinefelter’s syndrome. Mol Hum Reprod. 2010;16(6):386–95.PubMedCrossRef
5.
Lahlou N et al. Clinical and hormonal status of infants with nonmosaic XXY karyotype. Acta Paediatr. 2011;100(6):824–9.PubMedCrossRef
6.
7.
Bojesen A, Juul S, Gravholt CH. Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab. 2003;88(2):622–6.PubMedCrossRef
8.
Swerdloff RS, Wang CCL. Review of guidelines on diagnosis and treatment of testosterone deficiency. In: Nieschlag E, Behre HM, editors. Testosterone: action, deficiency, substitution. 4th ed. Cambridge: Cambridge University Press; 2012. p. 408–20.CrossRef
9.
Brooimans RA, van den Berg AJ, Rijkers GT, Sanders LA, van Amstel JK, Tilanus MG, et al. Identification of novel Bruton’s tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia. J Med Genet. 1997;34(6):484–8.PubMedCentralPubMedCrossRef
10.
Mattsson PT, Lappalainen I, Bäckesjö CM, Brockmann E, Laurén S, Vihinen M, et al. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton’s tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis. J Immunol. 2000;164(8):4170–7.PubMed
11.
Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66 Suppl 2:ii1–ii23.PubMedCrossRef
12.
Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of america. Clin Infect Dis. 2011;53(7):e25–76.PubMedCrossRef
13.
de Vries E. European society for immunodeficiencies (ESID) members. Patient-centred screening for primary immunodeficiency, a multistage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2012;167:108–19.PubMedCentralPubMedCrossRef
14.
Vancikova Z et al. X-linked agammaglobulinemia in community-acquired pneumonia cases revealed by immunoglobulin level screening at hospital admission. Klin Padiatr. 2013;225:1–5.CrossRef
15.
Harvey J et al. The parental origin of 47, XXY males. Birth Defects Orig Artic Ser. 1990;26(4):289–96.PubMed
16.
Jacobs PA, Hassold TJ, Whittington E, Butler G, Collyer S, Keston M, et al. Klinefelter’s syndrome: an analysis of the origin of the additional sex chromosome using molecular probes. Ann Hum Genet. 1988;52(Pt 2):93–109.PubMedCrossRef
17.
18.
Allen RC et al. Application of carrier testing to genetic counseling for X-linked agammaglobulinemia. Am J Hum Genet. 1994;54(1):25–35.PubMedCentralPubMed
19.
Schejbel L et al. Properdin deficiency associated with recurrent otitis media and pneumonia, and identification of male carrier with Klinefelter syndrome. Clin Immunol. 2009;131(3):456–62.PubMedCrossRef
20.
Buinauskaite E et al. Incontinentia pigmenti in a male infant with Klinefelter syndrome: a case report and review of the literature. Pediatr Dermatol. 2010;27(5):492–5.PubMedCrossRef
21.
Sanders DY, Goodman HO, Cooper MR. Chronic granulomatous disease in a child with Klinefelter’s syndrome. Pediatrics. 1974;54(3):373–5.PubMed
22.
Daly JJ, Hunter H, Rickards DF. Klinefelter’s syndrome and pulmonary disease. Am Rev Respir Dis. 1968;98(4):717–9.PubMed
23.
Harris A, Docherty Z. X-linked lymphoproliferative disease: a karyotype analysis. Cytogenet Cell Genet. 1988;47:92–4.PubMedCrossRef
24.
Gill HK, Kumar HC, Cheng CK, Ming CC, Nallusamy R, Yusoff NM, et al. X-linked chronic granulomatous disease in a male child with an X-CGD carrier, Klinefelter brother. Asian Pac J Allergy Immunol. 2013;31(2):167–72.PubMedCrossRef
25.
Balci YI, Turul T, Daar G, Anak S, Devecioglu O, Tezcan I, et al. Hematopoietic stem cell transplantation from a donor with Klinefelter syndrome for Wiskott-Aldrich syndrome. Pediatr Transplant. 2008;12:597–9.PubMedCrossRef
26.
27.
Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol. 2010;10(8):594–604.PubMedCrossRef
28.
Pinheiro I, Dejager L, Libert C. X-chromosome-located microRNAs in immunity: might they explain male/female differences? The X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females. Bioessays. 2011;33(11):791–802.PubMedCrossRef
29.
Metadata
Title
X-Linked agammaglobulinemia in a child with Klinefelter’s syndrome
Authors
Alexis-Virgil Cochino
Ales Janda
Barbora Ravcukova
Vasilica Plaiasu
Diana Ochiana
Ioan Gherghina
Tomas Freiberger
Publication date
01-02-2014
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 2/2014
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-013-9986-y

Other articles of this Issue 2/2014

Journal of Clinical Immunology 2/2014 Go to the issue

Original Research

C3a, C5a Renal Expression and Their Receptors are Correlated to Severity of IgA Nephropathy

Original Research

Modeling Primary Immunodeficiency Disease Epidemiology and Its Treatment to Estimate Latent Therapeutic Demand for Immunoglobulin

Original Research

Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases

Brief Communication

Bone Density and Fractures in Autosomal Dominant Hyper IgE Syndrome

Astute Clinician Report

Autosomal Recessive Agammaglobulinemia: A Novel Non-sense Mutation in CD79a

Original Research

First Report of the Hyper-IgM Syndrome Registry of the Latin American Society for Immunodeficiencies: Novel Mutations, Unique Infections, and Outcomes
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits